NANOBIOTIX (NANO.PA)

FR0011341205 - Common Stock

8.3  +0.38 (+4.8%)

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.0010.00K50.00K68.00K116.00K
Operating Expenses
46.70M52.59M36.48M46.85M30.18M
Research and Development
31.28M29.17M23.04M28.78M20.36M
Selling, General, and Administrative Expenses
17.48M19.02M14.27M18.64M12.62M
Operating Income
-46.70M-52.58M-36.43M-46.78M-30.07M
Interest Income/Expense
-3.48M5.57M2.75M-4.27M-364.00K
Other Income/Expense
1.00K13.00K97.00K133.00K87.00K
Non Recurring Items
-6.86MN/AN/AN/AN/A
Income Before Taxes
-57.03M-47.00M-33.58M-50.91M-30.34M
Income Tax
10.00K5.00K9.00K3.00K0.00
Net Income
-57.04M-47.00M-33.59M-50.91M-30.34M
EBITDA
-45.20M-51.02M-34.67M-45.01M-29.45M
 
Per Share Data
EPS Diluted Total Ops
-1.64-1.35-1.38-2.35-1.55
Non GAAP EPS
N/A-1.35-1.40-2.35-1.55
 
Statistics
Profit Margin
N/A-470030.00%-67180.00%-74875.00%-26159.48%
Operating Profit Margin
N/A-525790.00%-72856.00%-68792.65%-25919.83%

All data in EUR

Charts